Affimer Proteins: Theranostics of the Future?
Stuart Kyle
Index: 10.1016/j.tibs.2018.03.001
Full Text: HTML
Abstract
Affimer proteins can bind to a wide variety of target molecules. They can complement and represent a promising alternative to conventional antibodies as they can target molecules with high affinity, specificity, and stability. In addition, they can be selected and expressed in bacterial and mammalian systems. Affimer protein technology shows promise as a tool in the biologist’s arsenal of the future in imaging, diagnostic, and therapeutic applications.
Latest Articles:
Hypothesis on the Synchronistic Evolution of Autotrophy and Heterotrophy
2018-04-11
[10.1016/j.tibs.2018.03.008]
Unraveling the Structure and Mechanism of the MST(ery) Enzymes
2018-03-21
[10.1016/j.tibs.2018.02.011]
A Lethal Channel between the ATP Synthase Monomers
2018-03-16
[10.1016/j.tibs.2018.02.013]
Evolving Linear Chromosomes and Telomeres: A C-Strand-Centric View
2018-03-14
[10.1016/j.tibs.2018.02.008]
Homing in: Mechanisms of Substrate Targeting by Protein Kinases
2018-03-12
[10.1016/j.tibs.2018.02.009]